Drug:
Reaction: DRUG HYPERSENSITIVITY
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26518719 |
CN |
||
Kounis syndrome, Condition aggravated, Drug hypersensitivity, |
||||
PANTOPRAZOLE, LANSOPRAZOLE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, CILOSTAZOL, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 202 | 26519093 |
CA |
65 | 2 |
Respiratory tract infection, Pneumonia, Drug hypersensitivity, Malaise, Oedema, Pain, Vomiting, |
||||
RITUXIMAB, OMALIZUMAB, OMALIZUMAB, CLONAZEPAM, |
||||
| 203 | 26519728 |
CA |
40 | 2 |
Abdominal discomfort, Alopecia, Confusional state, Decreased appetite, Discomfort, Drug hypersensitivity, Drug ineffective, Drug-induced liver injury, Dry mouth, Epilepsy, Fall, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, Glossodynia, Injection site reaction, Nausea, Off label use, Onychomadesis, Pemphigus, Pericarditis, Product use in unapproved indication, Rash, Rheumatic fever, Rheumatoid arthritis, Treatment failure, Urticaria, Wound, |
||||
SECUKINUMAB, SECUKINUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CALCIUM CARBONATE, ANTACID, ERGOCALCIFEROL, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, VITAMIN A, VITAMIN C, ERGOCALCIFEROL, POVIDONE-IODINE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, GOLIMUMAB, |
||||
| 204 | 26520226 |
JP |
67 | 2 |
Death, Thyroid disorder, Malignant neoplasm progression, Drug hypersensitivity, |
||||
PEMBROLIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), LENVATINIB, CARBOPLATIN, |
||||
| 205 | 26520652 |
US |
58 | |
Drug hypersensitivity, |
||||
| 206 | 26520666 |
US |
2 | |
Drug hypersensitivity, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 207 | 26521049 |
US |
36 | 2 |
Drug hypersensitivity, |
||||
| 208 | 26524200 |
|||
Drug ineffective, Contraindicated product administered, Drug hypersensitivity, |
||||
TIRZEPATIDE, |
||||
| 209 | 26512433 |
US |
2 | |
Drug hypersensitivity, |
||||
PENICILLIN G SODIUM, ALPRAZOLAM, ESCITALOPRAM, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, EPINEPHRINE, ADRENALINUM, |
||||
| 210 | 26512462 |
US |
1 | |
Intestinal resection, Arthralgia, Drug hypersensitivity, |
||||
INFLIXIMAB, HYDROCORTISONE, |
||||
| 211 | 26512631 |
US |
67 | 2 |
Skin exfoliation, Drug hypersensitivity, |
||||
FAMOTIDINE, OMADACYCLINE, CLARITHROMYCIN, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, |
||||
| 212 | 26512691 |
US |
1 | |
Rash, Drug hypersensitivity, |
||||
TOPIRAMATE, |
||||
| 213 | 26512952 |
US |
2 | |
Drug hypersensitivity, |
||||
PENICILLIN G SODIUM, ASCIMINIB, |
||||
| 214 | 26513521 |
US |
2 | |
Drug hypersensitivity, |
||||
PENICILLIN G SODIUM, |
||||
| 215 | 26513851 |
EU |
2 | |
Hypothyroidism, Drug hypersensitivity, |
||||
OLAPARIB, DURVALUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 216 | 26514165 |
CA |
65 | 2 |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
ROPIVACAINE HYDROCHLORIDE, AMLODIPINE BESYLATE, ROSUVASTATIN CALCIUM, CLONAZEPAM, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, RITUXIMAB, HYDROMORPHONE HYDROCHLORIDE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, ERGOCALCIFEROL, MONTELUKAST SODIUM, MONTELUKAST, TRAMADOL HYDROCHLORIDE, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, CALCIUM, CALCIUM, CALCIUM CARBONATE, ANTACID, ROSUVASTATIN, ROSUVASTATIN, FLUTICASONE FUROATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FOLIC ACID, OMALIZUMAB, OMALIZUMAB, ERGOCALCIFEROL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMINOPHYLLINE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CEFADROXIL, POLYMYXIN B SULFATE, |
||||
| 217 | 26514379 |
83 | ||
Drug hypersensitivity, Product dose omission issue, Platelet count increased, Oral disorder, |
||||
RUXOLITINIB, |
||||
| 218 | 26514462 |
US |
2 | |
Drug hypersensitivity, |
||||
DALFAMPRIDINE, |
||||
| 219 | 26514463 |
US |
2 | |
Drug hypersensitivity, |
||||
DALFAMPRIDINE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 220 | 26514483 |
US |
2 | |
Sensation of foreign body, Drug hypersensitivity, |
||||
DALFAMPRIDINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, |
||||
| 221 | 26514581 |
US |
1 | |
Drug hypersensitivity, |
||||
DALFAMPRIDINE, |
||||
| 222 | 26514648 |
US |
2 | |
Drug hypersensitivity, |
||||
DALFAMPRIDINE, GLATIRAMER ACETATE, |
||||
| 223 | 26514652 |
US |
1 | |
Drug hypersensitivity, |
||||
DALFAMPRIDINE, ISOSORBIDE MONONITRATE, |
||||
| 224 | 26514843 |
US |
50 | 2 |
Femur fracture, Fall, Palpitations, Energy increased, Lethargy, Asthenia, Peripheral swelling, Constipation, Malaise, Impaired healing, Anaesthetic complication, Arthralgia, Drug hypersensitivity, Dyspnoea, Anosmia, Osteoporosis, Lymphadenopathy, Deafness, Weight increased, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, CALCIUM CARBONATE, ANTACID, TORSEMIDE, |
||||
| 225 | 26514901 |
US |
1 | |
Arterial stent insertion, Drug hypersensitivity, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 226 | 26515014 |
US |
2 | |
Illness, Drug hypersensitivity, Drug hypersensitivity, |
||||
BUPRENORPHINE, ATOMOXETINE, |
||||
| 227 | 26515017 |
US |
1 | |
Drug hypersensitivity, |
||||
BUPRENORPHINE, BUPRENORPHINE, |
||||
| 228 | 26515031 |
US |
1 | |
Restlessness, Energy increased, Drug hypersensitivity, Insomnia, |
||||
BUPRENORPHINE, |
||||
| 229 | 26515298 |
US |
||
Generalised oedema, Drug hypersensitivity, |
||||
BUPRENORPHINE, |
||||
| 230 | 26515437 |
US |
80 | 2 |
Nausea, Peripheral swelling, Pruritus, Abdominal pain upper, Drug hypersensitivity, Product packaging issue, |
||||
DAPAGLIFLOZIN, |
||||
| 231 | 26515491 |
US |
64 | 2 |
Oral pain, Drug hypersensitivity, |
||||
METHOTREXATE SODIUM, PREDNISONE, |
||||
| 232 | 26515617 |
CA |
43 | 2 |
Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthma, Blister, Breast cancer stage III, Condition aggravated, Contraindicated product administered, Decreased appetite, Depression, Diarrhoea, Discomfort, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug tolerance decreased, Duodenal ulcer perforation, Maternal exposure during pregnancy, Fatigue, Fibromyalgia, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hypersensitivity, Hepatic enzyme increased, Infusion related reaction, Hypoaesthesia, Joint swelling, Pain, Pemphigus, Pericarditis, Off label use, Product use issue, Rash, Rheumatoid factor positive, Swelling, Synovitis, Systemic lupus erythematosus, Treatment failure, Wound, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 233 | 26516043 |
EU |
52 | 2 |
Syncope, Drug hypersensitivity, Loss of consciousness, |
||||
GLATIRAMER ACETATE, |
||||
| 234 | 26516105 |
US |
||
Drug hypersensitivity, |
||||
AFLIBERCEPT, |
||||
| 235 | 26516492 |
US |
1 | |
Scratch, Muscle twitching, Agitation, Bipolar disorder, Schizophrenia, Drug hypersensitivity, Somnambulism, Pruritus, |
||||
CARIPRAZINE, |
||||
| 236 | 26516670 |
US |
2 | |
Nervous system disorder, Drug hypersensitivity, |
||||
DALFAMPRIDINE, METOCLOPRAMIDE HYDROCHLORIDE, LINACLOTIDE, |
||||
| 237 | 26520235 |
64 | 2 | |
Drug hypersensitivity, Gait disturbance, Pain in extremity, Muscle spasms, Hypoaesthesia, Formication, Neuralgia, |
||||
DUPILUMAB, BUDESONIDE, MAGNESIUM, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 238 | 26507704 |
CA |
58 | 2 |
Abdominal discomfort, Back injury, Benign abdominal neoplasm, Benign ovarian tumour, Blood pressure diastolic abnormal, Blood pressure increased, Blood pressure increased, Blood pressure systolic abnormal, Blood pressure systolic increased, Body temperature decreased, Chills, Drug hypersensitivity, Fungal infection, Gait disturbance, Human papilloma virus test positive, Impaired healing, Infection, Influenza, Lip injury, Lower respiratory tract congestion, Migraine, Musculoskeletal stiffness, Nasopharyngitis, Oral herpes, Oral herpes, Oral herpes, Oral herpes, Oral pain, Oropharyngeal pain, Ovarian cyst, Oxygen saturation decreased, Pneumonia, Productive cough, Rheumatoid arthritis, Rhinorrhoea, Skin fissures, Sneezing, Stomatitis, Stomatitis, Tinnitus, Ulcer, Upper respiratory tract infection, Drug interaction, Back pain, Malaise, Gastrooesophageal reflux disease, Cough, Hepatic enzyme increased, Infusion related reaction, Nausea, Nausea, Pain, Paraesthesia, Weight decreased, Weight increased, Arthralgia, Drug ineffective, |
||||
PANTOPRAZOLE, RITUXIMAB, RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, CELECOXIB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FOLIC ACID, HYDROXYCHLOROQUINE SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, VITAMIN C, |
||||
| 239 | 26507717 |
CN |
25 | 1 |
Conjunctivitis, Vision blurred, Drug hypersensitivity, Eye discharge, Drug eruption, Eosinophil count increased, Skin disorder, Off label use, Off label use, Skin temperature increased, Lip disorder, Erythema, Rash, Swelling face, Swelling of eyelid, |
||||
PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, MEROPENEM, MEROPENEM, |
||||
| 240 | 26508133 |
US |
57 | 2 |
Drug hypersensitivity, |
||||
PENICILLIN G SODIUM, PROPRANOLOL HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LIOTHYRONINE SODIUM, |
||||
| 241 | 26508535 |
US |
||
Drug ineffective, Drug hypersensitivity, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 242 | 26508598 |
US |
61 | 2 |
Drug hypersensitivity, Blood pressure abnormal, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 243 | 26508618 |
CA |
65 | 2 |
Vomiting, Drug hypersensitivity, Malaise, Oedema, Pain, Pneumonia, Respiratory tract infection, |
||||
ROSUVASTATIN, ROPIVACAINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE BESYLATE, CALCIUM CARBONATE, ANTACID, CLONAZEPAM, ERGOCALCIFEROL, FOLIC ACID, MONTELUKAST SODIUM, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, RISEDRONATE SODIUM, RITUXIMAB, TRAMADOL HYDROCHLORIDE, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, |
||||
| 244 | 26508692 |
CA |
44 | 2 |
Rash, Pruritus, Pyrexia, Drug hypersensitivity, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Blister, Decreased appetite, Discomfort, |
||||
SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, OXYCODONE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ADALIMUMAB-ADAZ, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, VITAMIN C, CALCIUM CARBONATE, ANTACID, |
||||
| 245 | 26509105 |
US |
2 | |
Drug hypersensitivity, Rash, Rash, Food allergy, |
||||
| 246 | 26509192 |
US |
64 | 1 |
Drug hypersensitivity, |
||||
RELUGOLIX, |
||||
| 247 | 26509614 |
CA |
65 | 2 |
Pneumonia, Drug hypersensitivity, Oedema, Asthma, Dyspnoea, Wheezing, Vomiting, |
||||
RITUXIMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, HYDROMORPHONE HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, ROSUVASTATIN, OMALIZUMAB, CLONAZEPAM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ERGOCALCIFEROL, |
||||
| 248 | 26509731 |
TH |
49 | 2 |
Drug hypersensitivity, |
||||
OSIMERTINIB, |
||||
| 249 | 26509775 |
US |
2 | |
Blindness, Blood pressure increased, Drug hypersensitivity, Hepatic enzyme increased, |
||||
ADALIMUMAB, |
||||
| 250 | 26509969 |
TR |
318 | 2 |
Bartholin^s cyst, Drug hypersensitivity, Maternal exposure during pregnancy, |
||||
INSULIN DETEMIR, |
||||
| 251 | 26510225 |
EU |
37 | 2 |
Drug hypersensitivity, Muscle spasms, Dyspnoea, Drug ineffective, |
||||
GLATIRAMER, |
||||
| 252 | 26510243 |
|||
Urticaria, Drug hypersensitivity, |
||||
| 253 | 26510274 |
US |
55 | 2 |
Drug hypersensitivity, |
||||
TUCATINIB, |
||||
| 254 | 26510358 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, |
||||
CLONAZEPAM, PREDNISONE, OMALIZUMAB, FOLIC ACID, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE BESYLATE, CIPROFLOXACIN HYDROCHLORIDE, ROSUVASTATIN, ERGOCALCIFEROL, MONTELUKAST SODIUM, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, RISEDRONATE SODIUM, ROPIVACAINE HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, CALCIUM GLUCONATE, |
||||
| 255 | 26510394 |
US |
1 | |
Blindness, Drug hypersensitivity, Eye pruritus, |
||||
BIMATOPROST, BIMATOPROST, BENZALKONIUM CHLORIDE, BENZALKONIUM CHLORIDE 0.13%, ANTIBACTERIAL WET WIPES, DUAL ACTION ANTIBACTERIAL WIPES, ANTIBACTERIAL HAND WIPES, FIRST AID ANTISEPTIC FOAM, LIQUID HAND SOAP, SANITIZING HAND WIPES, DUAL ACTION ANTIMICROBIAL WIPES, |
||||
| 256 | 26511039 |
|||
Drug hypersensitivity, |
||||
LEVETIRACETAM, |
||||
| 257 | 26511161 |
51 | 2 | |
Drug hypersensitivity, Nausea, Pruritus, Discomfort, Vomiting, Depressed mood, Erythema, Skin temperature increased, Respiratory rate increased, |
||||
| 258 | 26511326 |
CA |
65 | 2 |
Asthma, Malaise, Oedema, Pain, Pneumonia, Respiratory tract infection, Wheezing, Drug hypersensitivity, Dyspnoea, Vomiting, |
||||
ROPIVACAINE HYDROCHLORIDE, AMLODIPINE BESYLATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, HYDROMORPHONE HYDROCHLORIDE, RISEDRONATE SODIUM, RITUXIMAB, ERGOCALCIFEROL, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, BECLOMETHASONE DIPROPIONATE, CALCIUM CARBONATE, ANTACID, CLONAZEPAM, ROSUVASTATIN, OMALIZUMAB, PREDNISONE, TRAMADOL HYDROCHLORIDE, |
||||
| 259 | 26511519 |
US |
2 | |
Blindness, Hypersomnia, Movement disorder, Dysstasia, Fatigue, Productive cough, Rash, Pruritus, Increased appetite, Energy increased, Phantosmia, Ear discomfort, Headache, Eye pain, Photopsia, Malaise, Blood pressure increased, Blepharospasm, Tooth extraction, Drug hypersensitivity, Vomiting, Pyrexia, Tremor, Gait disturbance, Motor dysfunction, Tinnitus, Facial pain, |
||||
CEMIPLIMAB-RWLC, CEMIPLIMAB-RWLC, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 260 | 26511624 |
US |
||
Drug hypersensitivity, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 261 | 26511627 |
US |
||
Drug hypersensitivity, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 262 | 26511791 |
CA |
40 | 2 |
Abdominal distension, Arthralgia, Arthropathy, Back injury, Blepharospasm, Blister, Breast cancer stage III, Bursitis, Coeliac disease, Condition aggravated, Confusional state, Contusion, Depression, Dizziness, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lung disorder, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Wheezing, Wound, Wound infection, Abdominal pain upper, Alopecia, Asthenia, Diarrhoea, Lower respiratory tract infection, Hepatitis, Drug-induced liver injury, Hypotension, Malaise, Nausea, Pneumonia, Rash, Vomiting, Abdominal discomfort, |
||||
AZATHIOPRINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CORTISONE ACETATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ERENUMAB-AOOE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, LAMOTRIGINE, LAMOTRIGINE, MEPOLIZUMAB, |
||||
| 263 | 26512168 |
EU |
41 | 2 |
Muscle spasms, Medical device change, Drug hypersensitivity, Therapeutic product effect incomplete, Deep brain stimulation, |
||||
FOSCARBIDOPA/FOSLEVODOPA, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 264 | 26514269 |
|||
Urticaria, Drug hypersensitivity, |
||||
| 265 | 26514666 |
|||
Drug hypersensitivity, Urticaria, |
||||
CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, |
||||
| 266 | 26514669 |
|||
Drug hypersensitivity, Vomiting, |
||||
| 267 | 26515792 |
88 | 2 | |
Rash, Drug hypersensitivity, |
||||
AMLODIPINE BESYLATE, |
||||
| 268 | 26502888 |
CN |
43 | 1 |
Drug hypersensitivity, Dizziness, Pyrexia, Dyspepsia, Vomiting, Fatigue, Diarrhoea, Vision blurred, Headache, |
||||
| 269 | 26502978 |
US |
||
Drug hypersensitivity, |
||||
| 270 | 26503164 |
CA |
65 | 2 |
Respiratory tract infection, Pneumonia, Drug hypersensitivity, Malaise, Oedema, Pain, Vomiting, |
||||
AMLODIPINE BESYLATE, RISEDRONATE SODIUM, MOXIFLOXACIN HYDROCHLORIDE, ROSUVASTATIN, RITUXIMAB, MONTELUKAST SODIUM, MONTELUKAST, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, ROPIVACAINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM CARBONATE, ANTACID, CLONAZEPAM, ROSUVASTATIN, ERGOCALCIFEROL, FOLIC ACID, OMALIZUMAB, TRAMADOL HYDROCHLORIDE, |
||||
| 271 | 26503205 |
US |
||
Drug hypersensitivity, |
||||
USTEKINUMAB, |
||||
| 272 | 26503407 |
|||
Drug hypersensitivity, Pruritus, Burning sensation, |
||||
BIMEKIZUMAB, |
||||
| 273 | 26503483 |
US |
2 | |
Nasal congestion, Drug hypersensitivity, Drug interaction, |
||||
METOPROLOL TARTRATE, METOPROLOL, DUPILUMAB, |
||||
| 274 | 26503771 |
48 | ||
Drug hypersensitivity, |
||||
BIMEKIZUMAB, |
||||
| 275 | 26503916 |
US |
67 | 2 |
Skin exfoliation, Drug hypersensitivity, |
||||
FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, OMADACYCLINE, CLARITHROMYCIN, FAMOTIDINE, |
||||
| 276 | 26503965 |
CH |
2 | |
Myelodysplastic syndrome, Acute myeloid leukaemia, Drug tolerance decreased, Drug hypersensitivity, Catheter site abscess, |
||||
VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, DECITABINE, DECITABINE, ENASIDENIB MESYLATE, ENASIDENIB MESYLATE, |
||||
| 277 | 26504018 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, |
||||
AMLODIPINE BESYLATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, HYDROMORPHONE HYDROCHLORIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, RISEDRONATE SODIUM, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, ROSUVASTATIN CALCIUM, MONTELUKAST SODIUM, MONTELUKAST, AMINOPHYLLINE, BECLOMETHASONE DIPROPIONATE, CLONAZEPAM, FOLIC ACID, OMALIZUMAB, TRAMADOL HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, |
||||
| 278 | 26504701 |
EU |
44 | 2 |
Drug hypersensitivity, Wrong drug, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
| 279 | 26505078 |
2 | ||
Fall, Arthralgia, Pyrexia, Influenza like illness, Wrong technique in device usage process, Mucosal haemorrhage, Loss of consciousness, Hypertension, Hyperlipidaemia, Drug hypersensitivity, |
||||
BACILLUS CALMETTE-GUERIN, |
||||
| 280 | 26505169 |
68 | 2 | |
Drug hypersensitivity, Photosensitivity reaction, Atrial fibrillation, |
||||
TUBERCULIN PURIFIED PROTEIN DERIVATIVE, |
||||
| 281 | 26505384 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, |
||||
ROSUVASTATIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, RITUXIMAB, AMINOPHYLLINE, AMLODIPINE BESYLATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLONAZEPAM, FOLIC ACID, HYDROMORPHONE HYDROCHLORIDE, OMALIZUMAB, RISEDRONATE SODIUM, MONTELUKAST SODIUM, TRAMADOL HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, |
||||
| 282 | 26505581 |
78 | 2 | |
Rash, Swelling face, Drug hypersensitivity, |
||||
LENALIDOMIDE, |
||||
| 283 | 26505741 |
CA |
65 | 2 |
Asthma, Malaise, Oedema, Pain, Pneumonia, Respiratory tract infection, Wheezing, Drug hypersensitivity, Dyspnoea, Vomiting, |
||||
ROSUVASTATIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ROPIVACAINE HYDROCHLORIDE, FLUTICASONE PROPIONATE AND SALMETEROL, AMLODIPINE BESYLATE, CALCIUM CARBONATE, ANTACID, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLONAZEPAM, ERGOCALCIFEROL, HYDROMORPHONE HYDROCHLORIDE, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, PREDNISONE, RISEDRONATE SODIUM, RITUXIMAB, MONTELUKAST SODIUM, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, TRAMADOL HYDROCHLORIDE, |
||||
| 284 | 26505847 |
CA |
63 | 2 |
Vitamin B12 decreased, Back pain, Ear infection, Ear pain, Facet joint syndrome, Fall, General physical health deterioration, Hand fracture, Impetigo, Inappropriate schedule of product administration, Joint dislocation, Lower respiratory tract infection, Scoliosis, Tendon rupture, Tooth fracture, Upper limb fracture, Weight decreased, Weight increased, Drug hypersensitivity, |
||||
CYANOCOBALAMIN, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, CANNABIDIOL, CANNABIDIOL, LEVOTHYROXINE SODIUM, ERGOCALCIFEROL, |
||||
| 285 | 26505886 |
US |
78 | 1 |
Drug hypersensitivity, |
||||
LENALIDOMIDE, |
||||
| 286 | 26505947 |
45 | 2 | |
Drug hypersensitivity, |
||||
MAVACAMTEN, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 287 | 26506101 |
US |
64 | 2 |
Drug hypersensitivity, |
||||
GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, |
||||
| 288 | 26506104 |
US |
56 | 2 |
Nasal pruritus, Dry skin, Tinnitus, Fatigue, Seasonal allergy, Angioedema, Asthma, Reflux laryngitis, Oesophagitis, Pruritus, Type 2 diabetes mellitus, Vasomotor rhinitis, Drug hypersensitivity, |
||||
OMALIZUMAB, OMALIZUMAB, CRISABOROLE, PREGABALIN, PANTOPRAZOLE, ESCITALOPRAM OXALATE, ESCITALOPRAM, EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, LOSARTAN POTASSIUM, LOSARTAN, ZAFIRLUKAST, HYDROXYZINE, CETIRIZINE HYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PIMECROLIMUS, DOXYCYCLINE, DOXYCYCLINE HYCLATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, METHYLPREDNISOLONE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MOMETASONE, AZELASTINE HYDROCHLORIDE, AZELASTINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, EPINEPHRINE, |
||||
| 289 | 26506266 |
CA |
71 | 1 |
Salmonella sepsis, Drug hypersensitivity, |
||||
UPADACITINIB, |
||||
| 290 | 26506453 |
|||
Drug hypersensitivity, |
||||
LORATADINE, LORATADINE TABLET, |
||||
| 291 | 26506852 |
|||
Drug hypersensitivity, |
||||
| 292 | 26506863 |
AE |
16 | 1 |
Tubulointerstitial nephritis, Drug hypersensitivity, |
||||
LANSOPRAZOLE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, PANTOPRAZOLE, |
||||
| 293 | 26507084 |
JP |
65 | 2 |
Dyspnoea, Drug hypersensitivity, Lip swelling, Urticaria, Erythema, Chills, Pruritus, |
||||
OXALIPLATIN, CAPECITABINE, PANITUMUMAB, PANITUMUMAB, |
||||
| 294 | 26507179 |
US |
50 | 2 |
Loss of consciousness, Fall, Limb injury, Dizziness, Nausea, Drug hypersensitivity, Injection site swelling, |
||||
TIRZEPATIDE, |
||||
| 295 | 26507193 |
US |
2 | |
Drug hypersensitivity, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 296 | 26507195 |
US |
2 | |
Drug hypersensitivity, Dysphagia, Skin exfoliation, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 297 | 26507250 |
US |
16 | 1 |
Drug hypersensitivity, |
||||
AZACITIDINE, AZACITIDINE FOR, |
||||
| 298 | 26507261 |
US |
||
Dysphonia, Rash, Drug hypersensitivity, |
||||
RIMEGEPANT SULFATE, |
||||
| 299 | 26498162 |
US |
||
Anaphylactic reaction, Blood pressure decreased, Swelling, Drug hypersensitivity, |
||||
FERUMOXYTOL, FERUMOXYTOL, |
||||
| 300 | 26498174 |
US |
||
Swollen tongue, Drug hypersensitivity, Stomatitis, |
||||
UPADACITINIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28